Giulio Superti-Furga – Ri.MED Scientific Director and appointed Director of the Ri.MED Center – has been awarded the 2024 Lennart Philipson Award, in recognition of outstanding and validated contributions in translational research and/or technology innovation across the complete spectrum of life sciences. The ceremony took place in Heidelberg at the Scientific Symposium during which the Europen Molecular Biology Laboratory (EMBL) celebrated its 50th Anniversary
With this award, EMBL recognizes “Superti-Furga’s impact as a researcher which is multiplied through the leaders in science and beyond whom he has trained, the companies he has created, and the tools and methods he has shared with the life sciences community throughout his ongoing exceptional career. His contributions in basic science have endorsed the translation of basic research findings towards novel therapies, and in doing so he has helped support and develop the next generation of translational scientists. Through his leadership, he has encouraged scientists to take on responsibility in research management and other sectors of society”
Giulio Superti-Furga: “When I came to EMBL in 1991, I met Lennart Philipson, a true mentor who would share advice over walks, pipe in hand. EMBL, for me, has been a beacon of inspiration and support. This spirit has driven my work in community building and translational research at Cellzome, CeMM, startups in Vienna, and with EU-LIFE. It’s the backbone of my future projects in Sicily. The joy of discovery and the commitment to making a real impact in precision medicine are legacies of my EMBL experience.”